Antituberculotics and liver dysfunction - initial treatment and outcome

V. Dinic-Radovic, A. Nagorni, M. Radovic, V. Grozdanovic (Nis, Serbia And Montenegro)

Source: Annual Congress 2005 - Biology of tuberculosis
Session: Biology of tuberculosis
Session type: Thematic Poster Session
Number: 4161
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Dinic-Radovic, A. Nagorni, M. Radovic, V. Grozdanovic (Nis, Serbia And Montenegro). Antituberculotics and liver dysfunction - initial treatment and outcome. Eur Respir J 2005; 26: Suppl. 49, 4161

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients
Source: Eur Respir J 2001; 18: 306-315
Year: 2001



Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019
Year: 2020



Oxygenated hemoglobin predicts outcome in patients with chronic lung allograft dysfunction
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation
Source: Eur Respir J 2003; 22: 47S-56S
Year: 2003



Long-term management, functional outcome and results
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=179
Year: 2003

Does lung transplantation affect on the improvement of psychological status in patients with adult cystic fibrosis?
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018


Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series
Source: Eur Respir J 2006; 28: Suppl. 50, 263s
Year: 2006

Frequency, severity and risk factors of drug-induced liver injury during treatment of new tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012

Influence of lung infection on the course and outcome in patients with stroke
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Chronic kidney disease induces lung injury and mechanical alterations: gender differences and laser treatment.
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017

Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003


Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007

Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


The value of early lactate clearance in evaluating the prognosis of patients with respiratory failure
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009

Impact of pulmonary hypertension after lung transplantation on functional outcome
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010

Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020